Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Donskov, Frede
FASTERCC, NCT03581773: Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy	Recruiting	2	100	Europe	Folic Acid, Placebo Oral Tablet	Niels Fristrup	Mucositis, Stomatitis	12/26	12/28
NCT03616951: Improved Assessment of Response in Metastatic Renal Cell Carcinoma Using Spectral-CT	Recruiting	N/A	60	Europe		University of Aarhus	Renal Neoplasm With Metastasis, Response Evaluation Criteria in Solid Tumors	01/23	01/24
NCT04659343: TDM for Optimized Outcome in Patients With mRCC.	Recruiting	N/A	200	Europe	Measurement of concentration of active metabolite in cancer treatment., Measurement of autoantibodies and receptor polymorfia for CTLA-4 and PD-1 inhibition.	Niels Fristrup, Herlev Hospital, Rigshospitalet, Denmark	Kidney Cancer, Renal Cell Carcinoma Metastatic, Drug Toxicity, Drug Side Effect, Drug Mechanism	08/28	08/29

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Donskov, Frede
FASTERCC, NCT03581773: Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy	Recruiting	2	100	Europe	Folic Acid, Placebo Oral Tablet	Niels Fristrup	Mucositis, Stomatitis	12/26	12/28
NCT03616951: Improved Assessment of Response in Metastatic Renal Cell Carcinoma Using Spectral-CT	Recruiting	N/A	60	Europe		University of Aarhus	Renal Neoplasm With Metastasis, Response Evaluation Criteria in Solid Tumors	01/23	01/24
NCT04659343: TDM for Optimized Outcome in Patients With mRCC.	Recruiting	N/A	200	Europe	Measurement of concentration of active metabolite in cancer treatment., Measurement of autoantibodies and receptor polymorfia for CTLA-4 and PD-1 inhibition.	Niels Fristrup, Herlev Hospital, Rigshospitalet, Denmark	Kidney Cancer, Renal Cell Carcinoma Metastatic, Drug Toxicity, Drug Side Effect, Drug Mechanism	08/28	08/29